Adam S. Cheifetz, M.D., is the Director of the Center for Inflammatory Bowel Disease (IBD) and Medical Director of Infusion Services at Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School. He is also Director of the Harvard Medical School Gastroenterology Clerkship Elective and Assistant Director of the Advanced Fellowship in IBD at Beth Israel Deaconess Medical Center. Dr. Cheifetz specializes in the treatment of Crohn’s disease, ulcerative colitis, and other inflammatory bowel diseases. In addition to his clinical work, he is involved in multiple IBD research projects and has published over 200 articles and chapters on the subject. Dr. Cheifetz has also published extensively on his current research focus of optimizing biologic utilization through the proactive use of drug concentrations and antibodies. He is a fellow of the American Gastroenterological Association and American College of Gastroenterology. Dr. Cheifetz graduated magna cum laude from Brown University before earning his M.D. from Cornell University Medical College. He completed his internship and residency in Internal Medicine at Yale-New Haven Hospital and his fellowship in Gastroenterology at Yale University before serving as the Present-Levinson Fellow in IBD at the Mount Sinai Medical Center.